without_worries

Vaxart, Inc.

Panjang
without_worries Telah dikemas kini   
NASDAQ:VXRT   Vaxart, Inc. - Common Stock
A big thank you to all for helping me reach the 8k follower milestone..

On the above weekly chart price action has corrected over 90% since February 2020. A number of reasons now exist to be bullish, including:

1) You know why..
2) Price action confirms support on past resistance.
3) The support is on the Fibonacci 0.236
4) RSI resistance breakout.

Is it possible price action falls further? Sure.
Is it probable? No.

Ww

Type: investment
Risk: <=6% of portfolio
Timeframe: Now
Return: Will say elsewhere
Stop loss: Will say elsewhere
Komen:
hint hint nudge nudge, did you miss the Vroom trade...
Dagangan aktif:
Back up the truck and fill it up..
Komen:
20% since last update, coincidence?
Dagangan aktif:
support confirmed
Komen:
Support confirmed (again).

Don't think this is one you want to ignore...
Dagangan aktif:
If you missed out on Gamestop going 100x....
Dagangan aktif
Komen:
Why the sudden price jump?

Should you not know..

Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury.

Most recently:

“The company aims to advance its oral pill vaccine platform, citing positive clinical proof of data.”

Make no mistake the impact to the vaccine delivery this would have throughout the world, especially throughout countries in Africa and hard to reach places in Asia where refrigeration is not always available.

Yesterday's jump in price action came from the sell of $10m of preferred stock to RA Capital Management who specialises in evidence based investing in healthcare. They know something I don’t…

Follow the money..
Ww

www.racap.com
Komen:
GRM support confirmed.
Dagangan aktif
Komen:
Testing past resistance as support.
Komen:
Rapidly approaching next resistance for support test.

2-day

BTC
bc1q2eckdzh0q8vsd7swcc8et6ze7s99khhxyl7zwy

Weblink: www.patreon.com/withoutworries

Allow 3-6 months on ideas. Not investment advice. DYOR
Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.